Top Analysts Recommend 3 Best Stocks to Purchase Now, 11/20/2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 20 2025
0mins
Should l Buy ALAB?
Source: TipRanks
Top Stock Picks: Analysts have identified Nvidia, Astera Labs, and Capital One Financial as strong buy stocks, each receiving recent buy ratings and significant upside potential.
Nvidia (NVDA): The semiconductor company has seen positive market sentiment following strong Q3 results, with 36 out of 37 top analysts rating it a buy and a projected upside of about 30.85%.
Astera Labs (ALAB): This company specializes in chips for AI data centers, with 11 out of 13 top analysts giving it a buy rating and a projected upside of approximately 47.24%.
Capital One Financial (COF): The major U.S. bank has a buy rating from 10 out of 13 top analysts, with an increased price target suggesting an upside of about 28.15%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALAB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALAB
Wall Street analysts forecast ALAB stock price to rise
19 Analyst Rating
14 Buy
5 Hold
0 Sell
Moderate Buy
Current: 175.800
Low
155.00
Averages
206.18
High
250.00
Current: 175.800
Low
155.00
Averages
206.18
High
250.00
About ALAB
Astera Labs, Inc. is a global semiconductor company. The Company provides semiconductor-based connectivity solutions for cloud and artificial intelligence (AI) infrastructure. It has developed and deployed its Intelligent Connectivity Platform built from the ground up for cloud and AI infrastructure. Its Intelligent Connectivity Platform provides its customers with the ability to deploy and operate high-performance cloud and AI infrastructure at scale, addressing an increasingly diverse set of requirements. It provides its connectivity products in various form factors, including Integrated Circuits (ICs), boards, and modules. Its PCIe, CXL and Ethernet semiconductor-based connectivity solutions are purpose-built to unleash the potential of accelerated computing at cloud-scale. The Company’s products include Aries products, which include its COSMOS software suite; Taurus products, which are hardware modules based on its Taurus ICs; Leo products; and Scorpio products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Astera Labs Shares Surge 10% on Amazon's $100B Deal with Anthropic
- Stock Surge: Astera Labs (ALAB) shares rose 10% during Tuesday morning trading, primarily driven by Amazon's (AMZN) $100 billion deal with Anthropic (ANTHRO), reflecting market optimism about its growth prospects.
- Analyst Rating: UBS initiated coverage of Astera Labs with a Neutral rating and a $180 price target, noting that while product quality and execution have been validated, high valuation and increasing competition warranted a cautious stance.
- Market Outlook: UBS analysts project that Astera Labs' revenues will exceed consensus by 4% over the next 2-3 years, primarily driven by its retimer products and expanded PCIe/UA Link switching portfolio, showcasing the company's ongoing innovation in technology.
- Competitive Risks: Although Astera Labs is expected to capture around 25% market share in the PCIe switching market by 2030, analysts highlight significant risks from strong competitors like Broadcom and Microchip, necessitating sustained high execution standards from the company.
See More
Marvell Technology to Benefit from Amazon-Anthropic Partnership Expansion
- Investment Scale: Anthropic announced it will invest over $100 billion in Amazon Web Services over the next decade to support the training and operation of its Claude large language models, aiming to secure up to 5 gigawatts of new capacity, significantly enhancing its competitive edge in AI technology.
- Key Role of Marvell: As a long-standing partner for Amazon's Trainium chips, Marvell supplies optical processors and other hardware, with analysts noting that the ramp-up of Trainium 3 will enhance Marvell's potential gains in Trainium 4, driving future growth for the company.
- Price Target Increase: RBC Capital Markets raised Marvell's price target from $115 to $170, reflecting optimistic market expectations for increased demand in AI chips and data center hardware, with current stock trading around $150, indicating strong market confidence.
- AI Market Outlook: With Anthropic's commitment to Amazon, demand for Marvell's ethernet switches and data processing units is expected to surge, and analysts believe this will lead to robust double-digit growth momentum, further solidifying its position in the AI hardware market.
See More
Astera Labs Shares Surge Amid Amazon Partnership
- Stock Surge: Astera Labs shares rose 9.85% today to $17.32, reflecting market optimism about future growth potential, particularly following the deepening partnership with Amazon.
- Partnership Expansion: Amazon's expanded collaboration with AI platform Anthropic, committing over $100 billion over the next decade, directly benefits Astera Labs as it supplies critical technology for Amazon's Trainium processors.
- Revenue Forecast Upgrade: RBC Capital analyst raised the price target for Astera Labs from $225 to $250, projecting Scorpio switch revenue to increase from $130 million in 2025 to $390 million in 2026, indicating strong market demand.
- Market Risk Advisory: Despite the positive outlook, Astera Labs' stock remains priced over 50 times next year's earnings, indicating a high valuation, prompting investors to consider the associated volatility and market risks carefully.
See More
Astera Labs Stock Soars Following Amazon-Anthropic Deal
- Significant Stock Surge: Astera Labs (ALAB) shares surged over 8% on Tuesday, extending a remarkable rally that has seen the stock rise more than 60% in April, reflecting strong market optimism regarding suppliers linked to Amazon.
- Analyst Optimism: RBC raised its price target for Astera Labs from $225 to $250 while maintaining an 'Outperform' rating, indicating increased confidence in 2027 estimates and suggesting a 43% upside potential for the stock.
- Future Growth Challenges: UBS expressed a constructive outlook on Astera Labs' growth prospects over the next three years, although it noted that the company must compete in a more challenging switching market, highlighting intensifying market competition.
- Retail Trader Sentiment: Despite a 1,200% surge in message volume on Stocktwits within 24 hours, retail sentiment remains 'bullish', with one user predicting the company's market cap could double by year-end, currently around $30 billion.
See More
ASTERA LABS, INC: RBC Increases Target Price from $225 to $250
- Company Announcement: Aster Labs, Inc. has raised its price target for RBC to $250, up from a previous target of $225.
- Market Impact: This adjustment reflects a positive outlook on RBC's performance and potential growth in the market.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $4.37 Million in Common Stock via Form 144
Stock Sale Announcement: Aster Labs plans to sell 24,998 shares of its common stock on April 17.
Market Value: The total market value of the shares being sold is approximately $4.37 million.
See More
Astera Labs Shares Surge 10% on Amazon's $100B Deal with Anthropic
- Stock Surge: Astera Labs (ALAB) shares rose 10% during Tuesday morning trading, primarily driven by Amazon's (AMZN) $100 billion deal with Anthropic (ANTHRO), reflecting market optimism about its growth prospects.
- Analyst Rating: UBS initiated coverage of Astera Labs with a Neutral rating and a $180 price target, noting that while product quality and execution have been validated, high valuation and increasing competition warranted a cautious stance.
- Market Outlook: UBS analysts project that Astera Labs' revenues will exceed consensus by 4% over the next 2-3 years, primarily driven by its retimer products and expanded PCIe/UA Link switching portfolio, showcasing the company's ongoing innovation in technology.
- Competitive Risks: Although Astera Labs is expected to capture around 25% market share in the PCIe switching market by 2030, analysts highlight significant risks from strong competitors like Broadcom and Microchip, necessitating sustained high execution standards from the company.
See More
Marvell Technology to Benefit from Amazon-Anthropic Partnership Expansion
- Investment Scale: Anthropic announced it will invest over $100 billion in Amazon Web Services over the next decade to support the training and operation of its Claude large language models, aiming to secure up to 5 gigawatts of new capacity, significantly enhancing its competitive edge in AI technology.
- Key Role of Marvell: As a long-standing partner for Amazon's Trainium chips, Marvell supplies optical processors and other hardware, with analysts noting that the ramp-up of Trainium 3 will enhance Marvell's potential gains in Trainium 4, driving future growth for the company.
- Price Target Increase: RBC Capital Markets raised Marvell's price target from $115 to $170, reflecting optimistic market expectations for increased demand in AI chips and data center hardware, with current stock trading around $150, indicating strong market confidence.
- AI Market Outlook: With Anthropic's commitment to Amazon, demand for Marvell's ethernet switches and data processing units is expected to surge, and analysts believe this will lead to robust double-digit growth momentum, further solidifying its position in the AI hardware market.
See More
Astera Labs Shares Surge Amid Amazon Partnership
- Stock Surge: Astera Labs shares rose 9.85% today to $17.32, reflecting market optimism about future growth potential, particularly following the deepening partnership with Amazon.
- Partnership Expansion: Amazon's expanded collaboration with AI platform Anthropic, committing over $100 billion over the next decade, directly benefits Astera Labs as it supplies critical technology for Amazon's Trainium processors.
- Revenue Forecast Upgrade: RBC Capital analyst raised the price target for Astera Labs from $225 to $250, projecting Scorpio switch revenue to increase from $130 million in 2025 to $390 million in 2026, indicating strong market demand.
- Market Risk Advisory: Despite the positive outlook, Astera Labs' stock remains priced over 50 times next year's earnings, indicating a high valuation, prompting investors to consider the associated volatility and market risks carefully.
See More
Astera Labs Stock Soars Following Amazon-Anthropic Deal
- Significant Stock Surge: Astera Labs (ALAB) shares surged over 8% on Tuesday, extending a remarkable rally that has seen the stock rise more than 60% in April, reflecting strong market optimism regarding suppliers linked to Amazon.
- Analyst Optimism: RBC raised its price target for Astera Labs from $225 to $250 while maintaining an 'Outperform' rating, indicating increased confidence in 2027 estimates and suggesting a 43% upside potential for the stock.
- Future Growth Challenges: UBS expressed a constructive outlook on Astera Labs' growth prospects over the next three years, although it noted that the company must compete in a more challenging switching market, highlighting intensifying market competition.
- Retail Trader Sentiment: Despite a 1,200% surge in message volume on Stocktwits within 24 hours, retail sentiment remains 'bullish', with one user predicting the company's market cap could double by year-end, currently around $30 billion.
See More
ASTERA LABS, INC: RBC Increases Target Price from $225 to $250
- Company Announcement: Aster Labs, Inc. has raised its price target for RBC to $250, up from a previous target of $225.
- Market Impact: This adjustment reflects a positive outlook on RBC's performance and potential growth in the market.
See More
Astera Labs (ALAB.US) Insider Plans to Sell $4.37 Million in Common Stock via Form 144
Stock Sale Announcement: Aster Labs plans to sell 24,998 shares of its common stock on April 17.
Market Value: The total market value of the shares being sold is approximately $4.37 million.
See More
